Insider Trading: Cardinal Health Inc (CAH)
CAH on New York Consolidated
47.79USD
17 May 2013
47.79USD
17 May 2013
Price Change (% chg)
$0.79 (+1.68%)
$0.79 (+1.68%)
Prev Close
$47.00
$47.00
Open
$47.03
$47.03
Day's High
$47.79
$47.79
Day's Low
$47.03
$47.03
Volume
5,090,839
5,090,839
Avg. Vol
3,592,245
3,592,245
52-wk High
$47.79
$47.79
52-wk Low
$36.91
$36.91
DARDEN CALVIN
| Trading Date | Type | Shares Traded | Price | Shares Held |
|---|---|---|---|---|
| 1 Nov 2012 | Buy | 3,406 | $0.00 | 18,131 |
| 1 Nov 2011 | Buy | 3,195 | $0.00 | 14,725 |
Institutional Holders
| % Shares Owned: | 87.78% |
| # of Holders: | 729 |
| Total Shares Held: | 300,040,795 |
| 3 Mo. Net Change: | -8,870,045 |
| # New Positions: | 85 |
| # Closed Positions: | 48 |
| # Increased Positions: | 351 |
| # Reduced Positions: | 263 |
| # Net Buyers: | 88 |
Officers & Directors
| Name | Age | Since | Current Position |
|---|---|---|---|
George Barrett |
57 | 2009 | Chairman of the Board, Chief Executive Officer |
Jeffrey Henderson |
47 | 2005 | Chief Financial Officer |
Donald Casey |
52 | 2012 | Chief Executive Officer - Medical Segment |
Michael Kaufmann |
49 | 2009 | Chief Executive Officer - Pharmaceutical Segment |
Stephen Falk |
47 | 2009 | Executive Vice President, General Counsel, Corporate Secretary |
Mark Blake |
41 | 2009 | Executive Vice President - Strategy and Corporate Development |
Craig Morford |
54 | 2009 | Chief Legal and Compliance Officer |
Carole Watkins |
52 | 2005 | Chief Human Resources Officer |
Colleen Arnold |
55 | 2007 | Independent Director |
Glenn Britt |
64 | 2009 | Independent Director |
Carrie Cox |
55 | 2009 | Independent Director |
Calvin Darden |
63 | 2005 | Independent Director |
Bruce Downey |
64 | 2009 | Independent Director |
John Finn |
66 | 1994 | Independent Director |
Clayton Jones |
63 | 2012 | Independent Director |
Gregory Kenny |
60 | 2007 | Independent Director |
David King |
56 | 2011 | Independent Director |
Richard Notebaert |
65 | 2008 | Independent Director |
Jean Spaulding |
65 | 2002 | Independent Director |
Sally Curley |
Senior Vice President, Investor Relations |

